Cited by 75Sexual Differentiation and DisordersGenetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesUrological Disorders and Treatments

Disorders of sex development (DSD): clinical service delivery in the United States

Open access
Rolston, Aimee M., Gardner, Melissa, van Leeuwen, Kathleen, Mohnach, Lauren, Keegan, Catherine, Délot, Emmanuèle, Vilain, Eric, Sandberg, David E. +2 more·2017·American Journal of Medical Genetics Part C: Seminars in Medical Genetics

Abstract

Following the principles of care recommended in the 2006 Consensus Statement on Disorders of Sex Development (DSD), along with input from representatives of peer support and advocacy groups, this study surveyed DSD clinical management practices at healthcare facilities in the United States. DSD are congenital conditions in which development of chromosomal, gonadal, or anatomic sex is atypical. Facilities providing care for patients with DSD were targeted for participation. Specialty providers completed a survey with questions in six broad categories: Institution Information, Nomenclature and Care Guidelines, Interdisciplinary Services, Staff and Community Education, DSD Management, and Research. Twenty‐two of 36 targeted sites (61%) participated. Differences were observed between sites with regard to what conditions were considered to be DSD. All sites reported some degree of involvement of pediatric urology and/or surgery and pediatric endocrinology in the care of DSD patients. Gynecology and neonatology were most frequently not represented. Wide variation was observed across sites in continuing education standards, obtaining informed consent for clinical procedures, and in specific clinical management practices. This survey is the first to assess DSD clinical management practices in the United States. The findings establish a baseline of current practices against which providers delivering care to these patients and their families can benchmark their efforts. Such surveys also provide a practical framework for collaboration in identifying opportunities for change that enhance health and quality of life outcomes for patients and families affected by DSD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajmg.c.31558

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Given the relative rarity of CAH, national and international registries are valuable in developing and testing best practices throughout the lifespan.

    “Given the relative rarity of CAH, national and international registries are valuable in developing and testing best practices throughout the lifespan (737).”

    From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [737]

    The Introduction (page unavailable) describes a U.S. DSD patient registry designed to inform clinical management, and the Discussion says participation in its network may enhance practices. The paper does not establish CAH’s rarity or address the value of national and international CAH registries for developing and testing best practices throughout the lifespan. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 13

  1. Ahmed SF Achermann JC Arlt W Balen AH Conway G Edwards ZL Elford S Hughes IA Izatt L Krone N Miles HL O’Toole S Perry L Sanders C Simmonds M Wallace AM Watt A Willis D 2011 UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development Clin Endocrinol (Oxf) 75 1 12 26 21521344 PMC3132446
  2. Brain CE Creighton SM Mushtaq I Carmichael PA Barnicoat A Honour JW Larcher V Achermann JC 2010 Holistic management of DSD Best Practice & Research Clinical Endocrinology & Metabolism 24 2 335 354 20541156 PMC2892742
  3. Burns KEA Duffett M Kho ME Meade MO Adhikari NKJ Sinuff T Cook DJ for the ACCADEMY Group 2008 A guide for the design and conduct of self-administered surveys of clinicians Can Med Assoc J 179 3 245 252 18663204 PMC2474876
  4. Farquhar CM Kofa EW Slutsky JR 2002 Clinicians’ attitudes to clinical practice guidelines: a systematic review Med J Australia 177 9 502 506 12405894
  5. Hachach-Haram N Benyon SL Eccles SJ Kirkpatrick WNA Kelly M Waterhouse N 2012 Facing the World: Audit of activity 2002–2010 J Plast Reconstr Aes 65 1312 1324 22704823
  6. Josso N Audi L Shaw G 2011 Regional variations in the management of testicular or ovotesticular disorders of sex development Sex Dev 5 5 225 234 22116534
  7. Kyriakou A Dessens A Bryce J Iotova V Juul A Krawczynski M Nordenskjold A Rozas M Sanders C Hiort O Ahmed S 2016 Current models of care for disorders of sex development – results from an International survey of specialist centres Orphanet Journal of Rare Diseases 11 155 27871307 PMC5117601
  8. Lee PA Houk CP Ahmed SF Hughes IA in collaboration with the participants in the International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology 2006 Consensus statement on management of intersex disorders Pediatrics 118 2 e488 500 16882788
  9. Lee PA Nordenstrom A Houk CP Ahmed SF Auchus R Baratz A Baratz Dalke K Liao LM Lin-Su K Looijenga LH 3rd Mazur T Meyer-Bahlburg HF Mouriquand P Quigley CA Sandberg DE Vilain E Witchel S Global DSD Update Consortium 2016 Global disorders of sex development update since 2006: Perceptions, approach and care Horm Res Paediat 85 3 158 180 26820577
  10. Pasterski V Prentice P Hughes I 2010 Consequences of the Chicago consensus on disorders of sex development (DSD): Current practices in Europe Arch Dis Child 95 8 618 623 19773218
  11. Sandberg D Callens N Wisniewski A 2015 Disorders of Sex Development (DSD): Networking and standardization considerations Horm Metab Res 47 05 387 393 25970713
  12. Stevens DP Marshall BC 2014 A decade of healthcare improvement in cystic fibrosis: lessons for other chronic diseases BMJ Qual Saf 23 Suppl 1 i1 i2 24608544
  13. Vayena E Brownsword R Edwards SJ Greshake B Kahn JP Ladher N Montgomery J O’Connor D O’Neill O Richards MP Rid A Sheehan M Wicks P Tasioulas J 2016 Research led by participants: a new social contract for a new kind of research J Med Ethics 42 4 216 219 25825527 PMC4819634

Cited by

Sorted by citations

Authors
Rolston, A. M., Gardner, M., van Leeuwen, K., Mohnach, L., Keegan, C., Délot, E., Vilain, E., Sandberg, D. E., Advocacy, M. O. T. D., & Advisory Network Accord Alliance
Affiliations
  • University of Michigan (US)
  • Department of Surgery Phoenix Children's Hospital Phoenix Arizona
  • University of California, Los Angeles (US)
Corresponding author
Sandberg, David E.
Venue
American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Publisher
Wiley
Published
2017-05-30
Volume
175
Issue
2
Pages
268-278
ISSN
  • 1552-4868 (ISSN-L)
  • 1552-4876
OpenAlex
W2617311585
Cited by
75
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 37 · 2022: 3 · 2021: 8 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 2 · 2014: 1
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • American Journal of Medical Genetics Part C Seminars in Medical Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD068138, DSD‐Translational Research Network)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
Keywords
disorders of sex development, clinical management practices, multidisciplinary care, pediatric urology, pediatric endocrinology, informed consent, continuing medical education, quality of care, United States
MeSH terms
Delivery of Health Care, Female, Humans, Male, Quality of Life, Surveys and Questionnaires, Disorders of Sex Development, United States, Sex Determination Processes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review